iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI) Trading Down 0% – Time to Sell?

Shares of iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDIGet Free Report) dropped 0% on Tuesday . The stock traded as low as $37.17 and last traded at $37.49. Approximately 2,178 shares were traded during mid-day trading, a decline of 61% from the average daily volume of 5,524 shares. The stock had previously closed at $37.50.

iShares LifePath Target Date 2065 ETF Stock Down 0.0%

The company’s 50-day moving average is $38.27 and its two-hundred day moving average is $37.90. The company has a market capitalization of $21.74 million, a P/E ratio of 20.19 and a beta of 0.90.

Institutional Trading of iShares LifePath Target Date 2065 ETF

An institutional investor recently bought a new position in iShares LifePath Target Date 2065 ETF stock. Orion Porfolio Solutions LLC acquired a new stake in shares of iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDIFree Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,554 shares of the company’s stock, valued at approximately $465,000. Orion Porfolio Solutions LLC owned 2.85% of iShares LifePath Target Date 2065 ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

iShares LifePath Target Date 2065 ETF Company Profile

(Get Free Report)

The iShares LifePath Target Date 2065 ETF (ITDI) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2065 ITDI was launched on Oct 17, 2023 and is issued by BlackRock.

Featured Stories

Receive News & Ratings for iShares LifePath Target Date 2065 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2065 ETF and related companies with MarketBeat.com's FREE daily email newsletter.